kabutan

COSMO BIO COMPANY, LIMITED(3386) Summary

3386
TSE Standard
COSMO BIO COMPANY, LIMITED
1,319
JPY
-14
(-1.05%)
Jan 29, 3:30 pm JST
8.62
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
17.4
PBR
0.81
Yield
3.79%
Margin Trading Ratio
49.12
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,333 JPY 8.70 USD
Previous Close Jan 28
1,333 JPY 8.73 USD
High Jan 29, 9:00 am
1,333 JPY 8.70 USD
Low Jan 29, 3:30 pm
1,319 JPY 8.62 USD
Volume
1,500
Trading Value
2.00M JPY 0.01M USD
VWAP
1322.4 JPY 8.63 USD
Minimum Trading Value
131,900 JPY 862 USD
Market Cap
7.98B JPY 0.05B USD
Number of Trades
13
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
65
1-Year High Nov 14, 2025
3,463
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 6,300 97,200 15.43
Jan 16, 2026 8,700 99,100 11.39
Jan 9, 2026 11,400 101,800 8.93
Dec 26, 2025 20,400 89,400 4.38
Dec 19, 2025 17,700 98,000 5.54
Company Profile
COSMO BIO COMPANY, LIMITED is a specialized trading company in the biotechnology field. The company sells research reagents, laboratory equipment, and clinical diagnostic reagents, and also engages in development and manufacturing.
Sector
Wholesale Trade
COSMO BIO COMPANY, LIMITED is a specialized trading company focused on supporting biotechnology research. The company procures cutting-edge research reagents, equipment, and clinical diagnostic reagents from suppliers and provides them to research institutions and companies both domestically and internationally. They also develop and manufacture their own products, and offer various contract services to support drug discovery. The company is particularly known for its unique products and services, including the production and sale of primary cultured cells, custom peptide synthesis, antibody production services, and protein manufacturing using chicken egg bioreactors. In Japan, sales are conducted through a nationwide network of distributors, while overseas business is primarily managed through their U.S. subsidiary. A key feature of COSMO BIO is its ability to efficiently match diverse products and services to the needs of researchers.